Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences

The Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences (SIAT) is a research institute under the Chinese Academy of Sciences, distinguished by its deep involvement in brain-computer interface (BCI) and neuroengineering research. Per a 2024 Gaorong Ventures profile, neuroengineer Li Xiaojian joined SIAT in 2018 after eight years at U.S. medical institutions, then spun out Weiling Medical—described as China's first company to achieve a full-stack implantable BCI technology chain—while maintaining what Gaorong characterized as a "deep cooperation" between the startup and SIAT . The institute appears in elsewhere's corpus primarily through this BCI commercialization pathway rather than through standalone institutional coverage; elsewhere's corpus does not cover SIAT's broader research scope, founding history, or organizational structure beyond these neurotechnology linkages.